These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3046382)

  • 21. Minaprine and dose response in depression. An investigation of two fixed doses of minaprine compared with imipramine.
    Montgomery SA; Baldwin DS; Priest RG; Steinert J; Patel A; Herrington RN; Livingston HM
    Pharmacopsychiatry; 1991 Sep; 24(5):168-74. PubMed ID: 1775522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S-adenosylmethionine blood levels in major depression: changes with drug treatment.
    Bell KM; Potkin SG; Carreon D; Plon L
    Acta Neurol Scand Suppl; 1994; 154():15-8. PubMed ID: 7941961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients.
    Arminen SL; Ikonen U; Pulkkinen P; Leinonen E; Mahlanen A; Koponen H; Kourula K; Ryyppö J; Korpela V; Lehtonen ML
    Acta Psychiatr Scand; 1994 Jun; 89(6):382-9. PubMed ID: 8085467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of S-adenosylmethionine (SAM) on prolactin in depressed patients.
    Thomas CS; Bottiglieri T; Edeh J; Carney MW; Reynolds EH; Toone BK
    Int Clin Psychopharmacol; 1987 Apr; 2(2):97-102. PubMed ID: 3298421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of alprazolam and imipramine for treatment of outpatient depression.
    Overall JE; Biggs J; Jacobs M; Holden K
    J Clin Psychiatry; 1987 Jan; 48(1):15-9. PubMed ID: 3542981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program.
    Sotsky SM; Glass DR; Shea MT; Pilkonis PA; Collins JF; Elkin I; Watkins JT; Imber SD; Leber WR; Moyer J
    Am J Psychiatry; 1991 Aug; 148(8):997-1008. PubMed ID: 1853989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients].
    Olié JP; Galinowski A; Lehert P; Lemonnier F; Lôo H
    Encephale; 1993; 19(4):333-40. PubMed ID: 8275921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine.
    Bottiglieri T; Godfrey P; Flynn T; Carney MW; Toone BK; Reynolds EH
    J Neurol Neurosurg Psychiatry; 1990 Dec; 53(12):1096-8. PubMed ID: 2292704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression.
    Reifler BV; Teri L; Raskind M; Veith R; Barnes R; White E; McLean P
    Am J Psychiatry; 1989 Jan; 146(1):45-9. PubMed ID: 2643356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of major affective disorder with fluvoxamine.
    Lapierre YD; Browne M; Horn E; Oyewumi LK; Sarantidis D; Roberts N; Badoe K; Tessier P
    J Clin Psychiatry; 1987 Feb; 48(2):65-8. PubMed ID: 3100510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amineptine versus imipramine. Double-blind controlled study].
    Oules J; Boscredon J
    Presse Med; 1983 Oct; 12(36):2243-6. PubMed ID: 6226963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E; Feighner J; Mandos LA; Rickels K
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of restrictive diagnosis for compliance to antidepressant drug therapy: alprazolam versus imipramine.
    Overall JE; Donachie ND; Faillace LA
    J Clin Psychiatry; 1987 Feb; 48(2):51-4. PubMed ID: 3542984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women.
    Salmaggi P; Bressa GM; Nicchia G; Coniglio M; La Greca P; Le Grazie C
    Psychother Psychosom; 1993; 59(1):34-40. PubMed ID: 8441793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of the efficacy of thiothixene and a chlorpromazine-imipramine combination for depression in schizophrenia.
    Becker RE
    Am J Psychiatry; 1983 Feb; 140(2):208-11. PubMed ID: 6336916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.